These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10051005)

  • 1. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
    Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
    J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
    Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML
    Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
    Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
    Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
    Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
    Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
    Wagner A; van der Klift H; Franken P; Wijnen J; Breukel C; Bezrookove V; Smits R; Kinarsky Y; Barrows A; Franklin B; Lynch J; Lynch H; Fodde R
    Genes Chromosomes Cancer; 2002 Sep; 35(1):49-57. PubMed ID: 12203789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome.
    Menéndez M; Castellví-Bel S; Pineda M; de Cid R; Muñoz J; González S; Teulé A; Balaguer F; Ramón y Cajal T; Reñé JM; Blanco I; Castells A; Capellà G
    Clin Genet; 2010 Aug; 78(2):186-90. PubMed ID: 20095990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
    Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
    Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
    Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
    Aaltonen LA; Peltomäki P; Mecklin JP; Järvinen H; Jass JR; Green JS; Lynch HT; Watson P; Tallqvist G; Juhola M
    Cancer Res; 1994 Apr; 54(7):1645-8. PubMed ID: 8137274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.
    Stuckless S; Parfrey PS; Woods MO; Cox J; Fitzgerald GW; Green JS; Green RC
    Fam Cancer; 2007; 6(1):1-12. PubMed ID: 17039271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
    Lin KM; Shashidharan M; Thorson AG; Ternent CA; Blatchford GJ; Christensen MA; Watson P; Lemon SJ; Franklin B; Karr B; Lynch J; Lynch HT
    J Gastrointest Surg; 1998; 2(1):67-71. PubMed ID: 9841970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC).
    Pistorius S; Görgens H; Krüger S; Engel C; Mangold E; Pagenstecher C; Holinski-Feder E; Moeslein G; von Knebel Doeberitz M; Rüschoff J; Karner-Hanusch J; Saeger HD; Schackert HK;
    Cancer Lett; 2006 Sep; 241(1):150-7. PubMed ID: 16337339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
    Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
    Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.
    Froggatt NJ; Brassett C; Koch DJ; Evans DG; Hodgson SV; Ponder BA; Maher ER
    J Med Genet; 1996 Sep; 33(9):726-30. PubMed ID: 8880570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation.
    Green J; O'Driscoll M; Barnes A; Maher ER; Bridge P; Shields K; Parfrey PS
    Dis Colon Rectum; 2002 Sep; 45(9):1223-32. PubMed ID: 12352241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent germline mutation in MSH2 arises frequently de novo.
    Desai DC; Lockman JC; Chadwick RB; Gao X; Percesepe A; Evans DG; Miyaki M; Yuen ST; Radice P; Maher ER; Wright FA; de La Chapelle A
    J Med Genet; 2000 Sep; 37(9):646-52. PubMed ID: 10978353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.